Announcements

26 June 2025
Vaccines | Notable Papers Published in 2024 in the “Epidemiology” Section

1. “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy”
by Andrea Ceccarelli, Federica Tamarri, Raffaella Angelini, Elizabeth Bakken, Ilaria Concari, Elsa Giannoccaro, Giada Domeniconi, Michela Morri, Chiara Reali, Francesca Righi et al.
Vaccines 2024, 12(1), 51; https://doi.org/10.3390/vaccines12010051
Full text available online: https://www.mdpi.com/2076-393X/12/1/51

2. “Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities”
by Gloria Rey-Benito, Desirée Pastor, Alvaro Whittembury, Regina Durón, Carmelita Pacis-Tirso, Pamela Bravo-Alcántara, Claudia Ortiz and Jon Andrus
Vaccines 2024, 12(6), 690; https://doi.org/10.3390/vaccines12060690
Full text available online: https://www.mdpi.com/2076-393X/12/6/690

3. “Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics”
by Amy K. Winter and William J. Moss
Vaccines 2024, 12(7), 814; https://doi.org/10.3390/vaccines12070814
Full text available online: https://www.mdpi.com/2076-393X/12/7/814

4. “Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine”
by Kurt Frey
Vaccines 2024, 12(7), 811; https://doi.org/10.3390/vaccines12070811
Full text available online: https://www.mdpi.com/2076-393X/12/7/811

5. “The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance”
by Paul A. Rota, Roger Evans, Myriam Corinne Ben Mamou, Gloria Rey-Benito, Lucky Sangal, Annick Dosseh, Amany Ghoniem, Charles R. Byabamazima, Maurice Demanou, Raydel Anderson et al.
Vaccines 2024, 12(8), 946; https://doi.org/10.3390/vaccines12080946
Full text available online: https://www.mdpi.com/2076-393X/12/8/946

6. “An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity”
by Emma Chang-Rabley, Menno C. van Zelm, Emily E. Ricotta and Emily S. J. Edwards
Vaccines 2024, 12(6), 675; https://doi.org/10.3390/vaccines12060675
Full text available online: https://www.mdpi.com/2076-393X/12/6/675

7. “Assessment of Epidemiological Trend of Influenza-Like Illness in Italy from 2010/2011 to 2023/2024 Season: Key Points to Optimize Future Vaccination Strategies against Influenza”
by Sara Boccalini and Angela Bechini
Vaccines 2024, 12(8), 841; https://doi.org/10.3390/vaccines12080841
Full text available online: https://www.mdpi.com/2076-393X/12/8/841

8. “Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data”
by Juana Claus, Thijs ten Doesschate, Esther Taks, Priya A. Debisarun, Gaby Smits, Rob van Binnendijk, Fiona van der Klis, Lilly M. Verhagen, Marien I. de Jonge, Marc J. M. Bonten et al.
Vaccines 2024, 12(6), 691; https://doi.org/10.3390/vaccines12060691
Full text available online: https://www.mdpi.com/2076-393X/12/6/691

9. “Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries”
by Thomas D. Filardo, Stephen N. Crooke, Bettina Bankamp, Kelley Raines, Adria D. Mathis, Tatiana M. Lanzieri, R. Suzanne Beard, Ludmila Perelygina, David E. Sugerman and Paul A. Rota
Vaccines 2024, 12(6), 697; https://doi.org/10.3390/vaccines12060697
Full text available online: https://www.mdpi.com/2076-393X/12/6/697

10. “Serosurveillance for Measles and Rubella”
by Allison M. Brady, Elina El-Badry, Eriko Padron-Regalado, Nicole A. Escudero González, Daniel L. Joo, Paul A. Rota and Stephen N. Crooke
Vaccines 2024, 12(7), 816; https://doi.org/10.3390/vaccines12070816
Full text available online: https://www.mdpi.com/2076-393X/12/7/816

26 June 2025
Vaccines Receives an Updated Impact Factor of 3.4


We are pleased to share that Vaccines (ISSN: 2076-393X) was awarded an updated Impact Factor of 3.4 in the 2024 Journal Citation Reports™ released by Clarivate™ in June 2025. Vaccines ranks in Q2 (85 out of 183) in the “Immunology” category and Q2 (75 out of 195) in the “Medicine, Research and Experimental” category. Vaccines ranks in the first quartile (Q1) in these two JCI-indexed subject areas.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

26 June 2025
Vaccines Receives an Increased CiteScore of 9.9


We are pleased to share that Vaccines (ISSN: 2076-393X) has received an increased CiteScore of 9.9 in June 2025.

Vaccines’ CiteScore ranks as follows:

  • Q1 (24 out of 275) in the “Pharmacology (medical)” category;
  • Q1 (36 out of 357) in the “Infectious Diseases” category;
  • Q1 (39 out of 321) in the “Pharmacology” category;
  • Q1 (25 out of 156) in the “Drug Discovery” category;
  • Q1 (47 out of 240) in the “Immunology” category.

You can find more statistics on our website.

The current CiteScores measure the average number of citations within a journal over a four-year window (2021–2024). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies, research evaluation and enable benchmarking of journal performance.

This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Vaccines and its growing impact in laboratory and clinical vaccine research, utilization and immunization.

26 June 2025
Meet Us at the 12th Congress on Trends in Medical Mycology (TIMM-12), 19–22 September 2025, Bilbao, Spain


Conference: 12th Congress on Trends in Medical Mycology (TIMM-12)

Date: 19–22 September 2025

Location: Bilbao, Spain

We are delighted to announce that MDPI will serve as an exhibitor at the 12th Congress on Trends in Medical Mycology (TIMM-12), taking place from 19 to 22 September 2025 in collaboration with the European Confederation of Medical Mycology (ECMM) and the Spanish Association of Mycology (AEM).

TIMM-12 will cover new, fascinating insights into the biology of fungi, intriguing host–fungal interactions, updated diagnostic and therapeutic management approaches, changing dynamics in clinical epidemiology, and the emergence of antifungal resistance and newly discovered fungal pathogens. The scientific topics are designed to be applicable from bench to bed for basic scientists in medical mycology, medical mycologists, microbiologists, and a wide range of clinicians specialized in adult or pediatric infectious diseases, hematology, oncology, transplantation medicine and primary immunodeficiencies, critical care, dermatology, and immunology and all others with an interest in medical mycology. TIMM-12 will be an excellent opportunity for all participants to meet face-to-face with old friends and colleagues, make new friends, and establish new collaborations in medical mycology.

Serving as both a sponsor and exhibitor underscores MDPI’s unwavering support for the dissemination of high-impact research in medical mycology. Our participation in TIMM-12 highlights our mission to accelerate open access knowledge exchange and facilitate global scientific collaboration. Researchers attending the conference will have the opportunity to engage with representatives from the following MDPI journals, all of which publish pioneering work covering fungal research and related disciplines:

The following open access journals will be represented at the conference:

We cordially invite all attendees to visit our exhibition booth to discuss potential collaborations, explore publishing opportunities, and learn more about our open access initiatives. Our delegates are eager to meet you, address your inquiries, and support your contributions to the field.

For further details about TIMM-12, please visit the official conference website: https://www.timm2025.org/.

17 June 2025
Meet Us at the 29th Annual Meeting of the Japanese Society of Travel and Health, 19–20 July 2025, Nara, Japan


Conference:
The 29th Annual Meeting of the Japanese Society of Travel and Health
Organization: Japanese Society of Travel and Health
Date: 19–20 July 2025
Place: Nara, Japan

Representatives from a number of MDPI journals will be attending the 29th Annual Meeting of the Japanese Society of Travel and Health as exhibitors. The meeting will be held in Nara, Japan, from 19 to 20 July 2025.

The Japanese Society of Travel and Health (JSTH), established in 1997, has been dedicated to advancing the field of travel medicine. The 29th Annual Conference, themed “Let's learn together and create together: a new era of Travel and Health that illuminates future travel”, will focus on the following key topics:

  • Infectious disease treatment, infection control, and vaccines;
  • Mental health, chronic disease management, and medical insurance;
  • Establishment and operations of travel clinics;
  • Latest trends, including digital transformation and AI.

As an interdisciplinary platform, this conference will bring physicians, nurses, pharmacists, and travel industry experts together to discuss the most pressing global health challenges.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference above, please feel free to visit our booth. Our delegates look forward to meeting you in person and to answering any questions you may have. For more information about the conference, please visit the following website: https://www.c-linkage.co.jp/jsth29/.

3 June 2025
MDPI INSIGHTS: The CEO's Letter #23 - MDPI Summits Spain & Italy, Ei Compendex, and Editorial Independence

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Highlights from the MDPI Spain Summit in Barcelona (21-22 May)

In May we hosted the MDPI Spain Summit in Barcelona – our second summit in the city following the inaugural one in November 2023.


Stefan Tochev (CEO, MDPI) at the MDPI Spain Summit in Barcelona, 22 May 2025.

Creating a space for exchange of views

The goal of our summits is to bring together Chief Editors of MDPI journals from across disciplines and institutions. These intimate gatherings provide a platform to present the latest developments at MDPI and to initiate open conversations about our journals, the future of open access, and the evolving landscape of scientific publishing.

Most importantly, these are opportunities for in-person connection, providing a more meaningful space for the exchange of views and for building long-term relationships.

Exploring the future of scientific publishing in Spain

The summit took place on 21–22 May and featured a mix of MDPI presentations (including two guest presentations), roundtable discussions, and Q&A sessions. On the first day, we held a focused session with our Chief Editors to gather feedback and have open discussions on their journal development, the peer-review process, and local accreditation systems.


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI, presents MDPI’s Editorial Process and Peer Review Quality Metrics at the MDPI Spain Summit in Barcelona, 22 May 2025.

I had the pleasure of opening the Summit with a welcome address and an overview of MDPI’s recent milestones. The agenda then included the following sessions:

  • MDPI and Recent Developments in the Spanish Market – Dr. Marta Colomer (Public Affairs Specialist, MDPI)
  • MDPI Editorial Process and Peer Review Quality Metrics – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Open Access in Spain – Dr. Remedios Melero (Researcher, CSIC – guest speaker)
  • AI in Publishing and MDPI's Actions – Dr. Enric Sayas (Business Analyst, MDPI), Daniele Raimondi (Data Scientist, MDPI), and Dr. Alexandre López-Borrull (Researcher, Universitat Oberta de Catalunya – guest speaker)
  • Publication Ethics – Ana Stankovic (Research Integrity and Publication Ethics, MDPI)
  • Opening and Closing remarks were provided by Rocksy Zhang (Editorial Director, MDPI)

We are extremely grateful for the strong engagement shown by our Editors, who were clearly appreciative of the event and the discussions we had. They felt seen and heard, which is a vital prerequisite for building open channels of communication and cultivating productive long-term collaborations.


MDPI colleagues during MDPI Spain Summit in Barcelona (22 May 2025).

A big thank-you to the entire Barcelona team for organizing such a successful event!

Upcoming MDPI Summit events:

  • Italy Summit – Rome (26–27 May)
  • US Summit – Boston, MA (5–6 June)
  • France Summit – Paris (12–13 June)
  • US Summit – Houston, TX (26–27 June)
  • UK Summit – London (16–17 September)
  • Germany Summit – Berlin (18–19 September)
  • Romania Summit – Bucharest (23–24 October)
    ...with more in between, and more to follow.

Impactful Research

50 MDPI Journals Now Indexed in Ei Compendex

Indexing is a key indicator of a journal’s scientific impact. An indexed journal gives research greater visibility and credibility within the global academic community and is recognized for its quality and relevance. While many of our journals are included in major databases such as Web of Science and Scopus, MDPI also places strong emphasis on journal inclusion in subject-specific indexing platforms that align with each journal’s scope. This ensures that when you publish with MDPI, you publish with impact.

I’m pleased to share that as at May 2025, 51 of our journals are now indexed in Ei Compendex, a leading bibliographic database for engineering and applied sciences. This is a major milestone that reflects both the quality or our editorial processes and the relevance of the research we publish in these fields.

“When you publish with MDPI, you publish with impact”

Discoverability and reach

Inclusion in Ei Compendex means greater discoverability for our authors and broader reach of our journals in the fields of engineering and technology. It improves our ability to support global research and innovation, while building MDPI’s reputation in the applied sciences. This recognition is the result of the dedicated work of our editorial teams, reviewers, and authors, and of our overall commitment to excellence in publishing.

You can read our full announcement here.

Appreciative thanks to everyone involved in reaching this milestone.

Inside MDPI

 

One Year of MDPI’s Seoul Office

On 29 April, we marked one year since the opening of our Seoul office, MDPI’s first local hub in South Korea. South Korea is a key market for MDPI, currently ranking as our sixth-largest contributor to the company’s total publications, with over 89,000 MDPI articles authored by individuals affiliated with Korean institutions. Over the past 12 months, the Seoul team has made great strides in building our visibility, networks, and presence in the region.

A few highlights from the past year


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, is the Office Manager of the Seoul office.

In its inaugural year, the Seoul office focused primarily on marketing and promotional activities to support the MDPI brand locally. During that time, the team concentrated on scholar visits to local institutions, attending academic conferences, and hosting editorial board meetings.

The team also secured 10 Institutional Open Access Program (IOAP) renewals, signed three new IOAP agreements, and established one new Society affiliation.

The Seoul office also hosted its first library book fair and reached over 1,000 followers on its LinkedIn channel, which is an encouraging indication of local visibility and engagement.

“The Seoul team has made strides in building our visibility, networks, and presence in the region”

Growth plans

Later this year, we are working on opening a new Seoul office in a more central location, with room for our growing team. The new space will bring us closer to other publishing partners and provide easier access to and from the airport. The Seoul office will continue to expand its efforts in outreach and engagement as its builds its presence in South Korea.

Warm thanks to the entire Seoul team for their hard work and dedication, and to all MDPI colleagues who have contributed to this exciting chapter in our global journey.

Coming Together for Science

Highlights from the MDPI Italy Summit in Rome (26–27 May)

We closed the month of May by hosting the first MDPI Italy Summit in Rome. This was an important event for us, as Italy has consistently ranked among the top ten countries globally for open access publications over the past decade.

MDPI and Italy: Facts & Figures

  • With over 144,000 publications (as at 31 May 2025), Italy is MDPI’s third largest contributor after China and the USA.
  • In 2024, MDPI was the second-largest publishing house in Italy.
  • The 7,165 Editorial Board Members (EBMs) drawn from Italian institutions represent 8.9% of all MDPI academic editors.
  • Among these, 319 serve as Editors-in-Chief (EiCs) or Section Editors-in-Chief (SEiCs).
  • Eleven Italian EBMs were recognized as 2024 Clarivate Highly Cited Researchers.
  • In 2024, MDPI received 24,873 review reports and collaborated with 88,578 reviewers from Italy.
  • 23,131 Guest Editors from Italian institutions led 4,827 Special Issues across 248 MDPI journals.
  • MDPI partners with over 900 institutions globally, of which 17 are in Italy.

The MDPI Italy Summit in Rome


Dr. Prof. Giulio Cerullo, EiC of Applied Sciences, at the MDPI Italy Summit in Rome (27 May 2025).

Held on 26–27 May, the MDPI Italy Summit brought together 25 Chief Editors from across our journal portfolio, including some of our largest journals such as Applied Sciences, to discuss MDPI’s latest developments and collaborations in the Italian market, our use of data intelligence and AI to support strategic decision-making, a look into our editorial process, peer-review quality metrics, and conversations around research integrity and community engagement.

The Summit featured MDPI presentations followed by Q&A and concluded with a roundtable discussion. On the evening of the 26th, we hosted a dinner with our Editors to connect personally, learn more about their research, and hear feedback on journal operations and the broader academic landscape in Italy.


Gathering of Editors-in-Chief and MDPI staff at the MDPI Italy Summit in Rome (27 May 2025).

Event Agenda – 27 May

Moderated by Maddalena Favaretto (Conference Scientific Advisor, MDPI), the program featured:

  • MDPI Overview, Achievements, Latest News and Future Developments – Stefan Tochev (CEO, MDPI)
  • Country Report: Italy – Dr. Laura Perez Martin (Conference Assistant, MDPI)
  • AI in Publishing and MDPI’s Actions – Dr. Andrea Perlato (Head of Data Analytics, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Andrea, Giulia


Panel Discussion with Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI), Dr. Andrea Perlato (Head of Data Analytics, MDPI) during the MDPI Italy Summit in Rome (27 May 2025).

A big thank-you to our Conference team and everyone who worked behind the scenes to make these events run smoothly.

Closing Thoughts

Upholding Editorial Independence in Scholarly Publishing

A recent MDPI blog post written by Dr. Ioana Craciun (Scientific Communications Specialist, MDPI), “Editorial Independence and Publisher Support: Collaborating to Uphold Integrity,” highlights the important balance between editorial autonomy and publisher collaboration in academic publishing.

As the leading fully Open Access scholarly publisher, we are proud to champion editorial independence within our publishing process.

Drawing from the Committee on Publication Ethics (COPE) guidelines, the article emphasizes that while editors must have the freedom to make decisions based on scholarly merit, publishers play a critical role in providing the necessary infrastructure and tools to support the editorial process. This collaborative approach ensures the integrity of the peer review process, builds trust among authors and readers, and upholds the quality and relevance of published content.

MDPI highlights its commitment to this model by investing in research integrity specialists, AI tools for plagiarism detection, and administrative support, all aimed at empowering editors to make independent, informed decisions.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 May 2025
Vaccines | Notable Papers Published in 2024 in the “Influenza Virus Vaccines” Section

1. “Mid-Term Estimates of Influenza Vaccine Effectiveness against the A(H1N1)pdm09 Prevalent Circulating Subtype in the 2023/24 Season: Data from the Sicilian RespiVirNet Surveillance System”
by Claudio Costantino, Walter Mazzucco, Giorgio Graziano, Carmelo Massimo Maida, Francesco Vitale and Fabio Tramuto
Vaccines 2024, 12(3), 305; https://doi.org/10.3390/vaccines12030305
Full text available online: https://www.mdpi.com/2076-393X/12/3/305

2. “Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases”
by Pere Godoy, Núria Soldevila, Ana Martínez, Sofia Godoy, Mireia Jané, Nuria Torner, Lesly Acosta, Cristina Rius, Àngela Domínguez and The Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working Group
Vaccines 2024, 12(2), 173; https://doi.org/10.3390/vaccines12020173
Full text available online: https://www.mdpi.com/2076-393X/12/2/173

3. “Very Broadly Effective Hemagglutinin-Directed Influenza Vaccines with Anti-Herpetic Activity”
by David C. Bloom, Cameron Lilly, William Canty, Nuria Vilaboa and Richard Voellmy
Vaccines 2024, 12(5), 537; https://doi.org/10.3390/vaccines12050537
Full text available online: https://www.mdpi.com/2076-393X/12/5/537

4. “Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience”
by Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Davide De Francesco, Chiara Tricella, Cinzia Fasola, Sabrina Ferrario, Anna Gambaro et al.
Vaccines 2024, 12(6), 642; https://doi.org/10.3390/vaccines12060642
Full text available online: https://www.mdpi.com/2076-393X/12/6/642

5. “Immunogenicity and Protective Efficacy of Dose-Sparing Epigraph Vaccine against H3 Swine Influenza A Virus”
by Erika Petro-Turnquist, Adthakorn Madapong, David Steffen and Eric A. Weaver
Vaccines 2024, 12(8), 943; https://doi.org/10.3390/vaccines12080943
Full text available online: https://www.mdpi.com/2076-393X/12/8/943

6. “Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice”
by A. T. M. Badruzzaman, Yu-Chieh Cheng, Wang-Chou Sung and Min-Shi Lee
Vaccines 2024, 12(6), 667; https://doi.org/10.3390/vaccines12060667
Full text available online: https://www.mdpi.com/2076-393X/12/6/667

7. “A Polysaccharide-Based Oral-Vaccine Delivery System and Adjuvant for the Influenza Virus Vaccine”
by Chaitanya K. Valiveti, Mrigendra Rajput, Neelu Thakur, Tooba Momin, Malabika Bhowmik and Hemachand Tummala
Vaccines 2024, 12(10), 1121; https://doi.org/10.3390/vaccines12101121
Full text available online: https://www.mdpi.com/2076-393X/12/10/1121

8. “An Optimised Live Attenuated Influenza Vaccine Ferret Efficacy Model Successfully Translates H1N1 Clinical Data”
by Katarzyna E. Schewe, Shaun Cooper, Jonathan Crowe, Steffan Llewellyn, Lydia Ritter, Kathryn A. Ryan and Oliver Dibben
Vaccines 2024, 12(11), 1275; https://doi.org/10.3390/vaccines12111275
Full text available online: https://www.mdpi.com/2076-393X/12/11/1275

9. “Intranasal M2SR and BM2SR Vaccine Viruses Do Not Shed or Transmit in Ferrets”
by Yasuko Hatta, Lindsay Hill-Batorski, Michael J. Moser, David Marshall, David A. Boltz, Landon Westfall, Renee Herber, Sally Sarawar and Pamuk Bilsel
Vaccines 2024, 12(11), 1228; https://doi.org/10.3390/vaccines12111228
Full text available online: https://www.mdpi.com/2076-393X/12/11/1228

10. “Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination”
by A. Riccomi, C. M. Trombetta, M. Dorrucci, D. Di Placido, N. Sanarico, F. Farchi, R. Giuseppetti, U. Villano, C. Marcantonio, S. Marchi et al.
Vaccines 2024, 12(4), 425; https://doi.org/10.3390/vaccines12040425
Full text available online: https://www.mdpi.com/2076-393X/12/4/425

23 May 2025
Meet Us at the 79th Annual Meeting of the Canadian Society of Otolaryngology (CSOHNS) | 31 May–1 June 2025, Fredericton, Canada


MDPI is pleased to announce its participation in the CSOHNS 79th Annual Meeting of the Canadian Society of Otolaryngology in Fredericton, Canada. We are thrilled to highlight a landmark collaboration: this year’s meeting will be presented in partnership with our esteemed peers at the Societé Française D’ORL from France! This event promises to be an unprecedented gathering of thought leaders and innovators from Canada, France, and around the world.

The following MDPI journals will be represented at the conference:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

22 May 2025
Topics Webinar | Ticks and Tick-Borne Pathogens: Understanding Risks and Strategies for Prevention, 21 May 2025


A message from the webinar Chair:

We invite you to join our upcoming webinar on the topic of ticks and tick-borne pathogens. The main goal of this webinar is to summarize the first volume of our Special Topic on MDPI journals which were part of the sponsorship of this editorial to the TTP11 Conference and to promote the second volume of this Topic which was set very recently following the success of the previous volume. This second volume continues to provide a platform for showcasing groundbreaking research, innovative methodologies, and promising discoveries in various facets of tick biology. The webinar will be organized into three key topics, with a talk from a senior researcher and two presentations from Ph.D. students actively working on each topic:

  1. Tick microbiota;
  2. Latest trends in ticks and tick-borne disease surveillance;
  3. Effective prevention and control strategies.

Do not miss out on this opportunity to enhance your knowledge and stay updated on these important topics that are on the rise, making awareness and prevention more critical than ever. We encourage you to participate actively and submit your questions during the webinar.

Webinar: Ticks and Tick-Borne Pathogens: Understanding Risks and Strategies for Prevention
Date: 21 May 2025
Time: 2.30 p.m. CEST | 8.30 a.m. EDT | 8.30 p.m. CDT Asia
Webinar ID: 832 6108 8276
More information: https://sciforum.net/event/topics-35

This is a free webinar. After registration, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording becomes available for viewing.

Register for free:


Program:

Speaker/Presentation

Time in CEST

Time in EDT

Time in CDT Asia

Dr. Alejandro Cabezas-Cruz
Chair Introduction

14:30–14:35

08:30–08:35

20:30–20:35

Ms. Salma Kaoutar Abdelali
Microbiota–pathogen interactions and pathogen–pathogen interactions in Hyalomma ticks

14:35–14:45

08:35–08:45

20:35–20:45

Ms. Lianet Abuin Denis 
The use of networks for the study of microbiota-pathogen interactions

14:45–14:55

08:45–08:55

20:45–20:55

Dr. Alejandro Cabezas-Cruz
Reevaluating the Jenner/Pasteur Paradigm of Vaccination

14:55–15:15

08:55–09:15

20:55–21:15

Q&A Session

15:15–15:25

09:15–09:25

21:15–21:25

Ms. Dagmara Wężyk
Unexplored faces of ticks: studying lesser-known species as the key to understanding global pathogen vectors

15:25–15:35

09:25–09:35

21:25–21:35

Mr. Keve Gergő
The role of birds in the dispersal of ticks and other arthropod vectors

15:35–15:45

09:35–09:45

21:35–21:45

Prof. Dr. Marco Rogério André
Novel piroplasmids in wild animals from Brazil

15:45–16:05

09:45–10:05

21:45–22:05

Q&A Session

16:05–16:15

10:05–10:15

22:05–22:15

Ms. Ana Laura Cano-Argüelles
Different strategies to develop anti tick vaccines against Ornithodoros soft ticks

16:15–16:25

10:15–10:25

22:15–22:25

Mr. Julio Enrique Duque Vizcaíno
Informatic tools for helping in the implementation of anti-tick vaccine production and commercialization

16:25–16:35

10:25–10:35

22:25–22:35

Dr. Alina Rodríguez-Mallon
What to keep in mind when applying anti-tick vaccines in the field

16:35–16:55

10:35–10:55

22:35–22:55

Q&A Session

16:55–17:05

10:55–11:05

22:55–23:05

Dr. Alejandro Cabezas-Cruz
Closing of Webinar

17:05–17:15

11:05–11:15

23:05–23:15


Webinar Chairs and Speakers:

  • Dr. Alejandro Cabezas-Cruz, UMR BIPAR (INRAE, Anses, EnvA), France;
  • Dr. Alina Rodríguez-Mallon, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba;
  • Ms. Salma Kaoutar Abdelali, University of Ferhat Abbas, Algeria;
  • Ms. Lianet Abuin Denis, Center for Genetic Engineering and Biotechnology (CIGB), Havana, Cuba;
  • Ms. Dagmara Wężyk, University of Warsaw, Poland;
  • Mr. Keve Gergő, University of Veterinary Medicine Budapest, Hungary;
  • Ms. Ana Laura Cano-Argüelles, Institute of Natural Resources and Agrobiology of Salamanca (IRNASA, CSIC), Spain;
  • Mr. Julio Enrique Duque Vizcaíno, Center for Genetic Engineering and Biotechnology (CIGB), Cuba).

Relevant Special Issue:
Ticks and Tick-Borne Pathogens: 2nd Edition
Topic Editors: Dr. Alina Rodríguez-Mallon and Dr. Alejandro Cabezas-Cruz
Deadline for submission: 31 March 2026

21 May 2025
Meet Us at the Canadian Breast Cancer Symposium 2025, 19–20 June 2025, Toronto, Canada


Conference:
Canadian Breast Cancer Symposium 2025
Date: 19–20 June 2025
Location: Hilton Downtown Toronto, Toronto, Canada

Learn about the latest research innovations and clinical updates that are changing the trajectory of care at the Canadian Breast Cancer Symposium. Taking a truly multidisciplinary approach, world-class experts share knowledge spanning surgery, radiation oncology, medical oncology, pathology, and primary care. Researchers also share innovative therapies and evidence-based approaches that can be translated into surgical and clinical practice.

The following MDPI journals will be presented:

Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://www.breastsymposium.ca/.

Back to TopTop